News | April 16, 2026
Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
In his new role, Karthik will lead human capital strategy and HR operations across these regions
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
